(181 days)
Not Found
No
The summary does not mention AI, ML, or any related concepts like training data, test data, or complex algorithms beyond basic safety cutoffs.
Yes
The device is intended for "relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation," and "temporary reduction in the appearance of cellulite," which are therapeutic applications.
No
The intended use of the device is for therapeutic purposes, such as pain relief, muscle spasm relief, and temporary reduction in cellulite. There is no mention of it being used to identify or diagnose any medical condition.
No
The device description explicitly lists multiple hardware components (handpieces, patient switch, cradle, etc.) and describes physical functions like RF, EMS, vacuum, and cooling, indicating it is a hardware device with integrated software.
Based on the provided information, the eMVFit (MVF-10M) Radio frequency device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The intended uses listed are for therapeutic purposes (relief of muscle aches, pain, spasm, improved blood circulation, cellulite reduction). These are applications directly on the human body for treatment or physical effect.
- Device Description: The description details a device with handpieces, RF and EMS functions, vacuum, cooling, and temperature sensing. These are all components and functions related to applying energy and physical effects to the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed to perform tests on biological samples outside of the body to provide diagnostic information. The eMVFit's function is to apply energy and physical effects to the body itself.
N/A
Intended Use / Indications for Use
The eMVFit (MVF-10M) Radio frequency is used for: · Relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation. · Temporary reduction in the appearance of cellulite.
Product codes (comma separated list FDA assigned to the subject device)
PBX, GEI
Device Description
eMVFit has MULTI handpiece, EMS handpiece, patient switch, cradle, distilled water injection hose & funnel, key switch and power cable. eMVFit has a user interface including an LCD touch screen and has MULTI mode and EMS mode. MULTI mode has RF and EMS functions that use the MULTI handpiece. In the case of RF, the target temperature can be set and a vacuum can be used together, and a cooling function can be used as a safety system to prevent burns on the skin surface. In addition, the MULTI handpiece has a temperature sensor, so the output is automatically turned off when the skin surface temperature exceeds 43 C. EMS mode has an EMS function that uses the EMS handpiece.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical (Bench) Performance Data:
- Basic safety and essential performance of the eMVFit was tested and evaluated according to the IEC 60601-1:2005/A2:2020.
- Effect to the device by electromagnetic disturbances was tested and evaluated according to the FDA-recognized consensus standard IEC 60601-1-2:2014/A1:2020.
- Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories was tested and evaluated according to the IEC 60601-2-2:2017/A1:2023.
- Risk management was recorded by referring to ISO 14971:2019.
- Usability was documented by referring to IEC 60601-1-6:2010/A2:2020.
- Biocompatibility was tested and evaluated according to ISO 10993-5:2009, ISO 10993-10:2021, and ISO 10993-23:2021.
- Software was tested and evaluated according to IEC 62304:2015
- Content of Premarket Submissions for Device Software Functions
The eMVFit passed all the testing in accordance with internal requirements, national standards, and international standards shown above, to support substantial equivalence of the subject device.
Also, to demonstrate that the eMVFit meets all design specifications and performance requirements, and to measure the accuracy of the output parameters of eMVFit and to compare the output parameters with predicate devices, nonclinical bench testing was performed in accordance with the internal process in compliance with the recommendations of the FDA Guidance for Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery.
The testing results support that the requirements for performance and electrical safety were met for the acceptance of the device. The eMVFit passed all testing and supports the claims of substantial equivalence to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" and "ADMINISTRATION" in blue text.
October 9, 2024
Weero Co., Ltd. Moon-young Han Regulatory Affairs A-605, Venture Valley II, 142-10, Saneop-Ro 156 Beon-Gil Gwonseon-Gu Suwon-Si Suwon, Gyeonggi-Do 16648 Korea. South
Re: K240991
Trade/Device Name: eMVFit (MVF-10M) Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting And Coagulation Device And Accessories Regulatory Class: Class II Product Code: PBX, GEI Dated: September 13, 2024 Received: September 13, 2024
Dear Moon-young Han:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrb/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
1
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
2
Sincerely,
Digitally signed by Long H. Chen
Long H. Chen -S-s
Date: 2024.10.09 09:18:09 -04'00'
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
Submission Number (if known)
Device Name
eMVFit (MVF-10M)
Indications for Use (Describe)
The eMVFit (MVF-10M) Radio frequency is used for:
· Relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation.
· Temporary reduction in the appearance of cellulite.
Type of Use (Select one or both, as applicable)
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
eMVFit
510(k) Summary
1. Submitter and US Official Correspondent
| Submitter : | WEERO Co.,Ltd. |
|---|---|
| Address: | A205 Venture Valley II, 142-10, Saneop-ro 156beon-gil, Gwonseon-gu, |
| Suwon-si, Gyeonggi-do, Republic of Korea | |
| Telephone No.: | +82-31-5182-8588 |
| Official Correspondent: | Moon-young Han |
|---|---|
| Correspondent: | WEERO Co.,Ltd. |
| Address: | A205 Venture Valley II, 142-10, Saneop-ro 156beon-gil, |
| Gwonseon-gu, Suwon-si, Gyeonggi-do, Republic of Korea | |
| Telephone No.: | +82-31-5182-8588 |
| Email: | ra@weeroweero.com |
2. Device Information
| Trade/Device Name: | eMVFit / MVF-10M |
|---|---|
| Regulation Name: | - Electrosurgical cutting and coagulation device and accessories |
| Classification Name: | - Massager, Vacuum, Radio Frequency Induced Heat |
| Product Code: | PBX |
| Device Class: | Class II (Regulation 21CFR878.4400) |
3. Predicate Device(Equivalent Legally Marketed Device)
| Manufacturer | Device | 510(k) No. |
|---|---|---|
| Main Predicate | ||
| INMODE LTD. | Embody System | K183450 |
4. Description of the Device
eMVFit has MULTI handpiece, EMS handpiece, patient switch, cradle, distilled water injection hose & funnel, key switch and power cable.
eMVFit has a user interface including an LCD touch screen and has MULTI mode and EMS mode.
MULTI mode has RF and EMS functions that use the MULTI handpiece.
In the case of RF, the target temperature can be set and a vacuum can be used together, and a cooling function can be used as a safety system to prevent burns on the skin surface.
In addition, the MULTI handpiece has a temperature sensor, so the output is automatically
turned off when the skin surface temperature exceeds 43°C.
EMS mode has an EMS function that uses the EMS handpiece.
5. Indications for use (intended use)
The eMVFit (MVF-10M) Radio frequency is used for:
- · Relief of minor muscle aches and pain, relief of muscle spasm, temporary improvement of local blood circulation.
- · Temporary reduction in the appearance of cellulite.
5
eMVFit
510(k) Summary
6. Substantial Equivalence Discussion
1) Comparison Information
- Main Predicate : PBX
| Name | Subject device | Predicate device | |
|---|---|---|---|
| Device Name | eMVFit(MVF-10M) | EmBody System | Comparison |
| Manufacturer | WEERO Co.,Ltd. | INMODE LTD. | |
| 510(k) No. | K183450 | ||
| Product Code, | |||
| Class | PBX, IPF | ||
| Class II | PBX, ISA | ||
| Class II | N/A | ||
| Indications | |||
| for use | Radio frequency is used for: | ||
| • Relief of minor muscle aches | |||
| and pain, relief of muscle spasm, | |||
| temporary improvement of local | |||
| blood circulation. | |||
| • Temporary reduction in the | |||
| appearance of cellulite. | The InMode EmBody System | ||
| with its designated hand pieces | |||
| is intended for the treatment of | |||
| the following medical | |||
| conditions; | |||
| The EmBodyPlus hand piece is | |||
| intended for the temporary | |||
| relief of minor muscle aches | |||
| and pain, temporary relief of | |||
| muscle spasm, and temporary | |||
| improvement of local blood | |||
| circulation | |||
| The EmBodyFX hand piece is | |||
| intended for the treatment of | |||
| the following medical | |||
| conditions using RF combined | |||
| with massage: | |||
| • Relief of' minor muscle aches | |||
| and pain, relief of muscle | |||
| spasm, temporary | |||
| improvement of local blood | |||
| circulation. | |||
| • Temporary reduction in the | |||
| appearance of cellulite. | The eMVFit device shares | ||
| the same intended for use | |||
| as EmBody System for the | |||
| RF technology (PBX | |||
| code). | |||
| Also, the eMVFit device | |||
| has less indications for use | |||
| than EmBody System. | |||
| Therefore, the eMVFit | |||
| device does not have new | |||
| indications for use | |||
| compared to the predicate | |||
| device for RF | |||
| technologies. This does not | |||
| raise new questions of | |||
| safety and effectiveness. | |||
| Energy Used / | |||
| Delivered | RF energy | RF energy | Same |
| Physical | |||
| specification: | |||
| Dimensions | Dimensions: | ||
| WDH | |||
| 17.3 x 27.5 x 47 in / | |||
| 44 x 70 x 120 cm | Dimensions: | ||
| WDH | |||
| 18.2 x 18.2 x 40 in / | |||
| 46 x 46 x 100 cm | Different | ||
| *Note 1 | |||
| Weight Console | Weight: 48 kg / 106 lbs | Weight: 20 kg / 44 lbs | Different |
| *Note 1 | |||
| Weight | |||
| Handpieces | MULTI handpiece | ||
| 0.52kg [1.1lb] | |||
| EMS handpiece | |||
| 0.42kg [0.9lb] | EmBodyPLUS Handpiece | ||
| 0.17kg [0.375lb] | |||
| EmBodyFX Handpiece | |||
| 0.90kg [2.00lb] | Different | ||
| *Note 1 | |||
| Performance | |||
| Specifications: | |||
| Main Line | |||
| Frequency | |||
| (nominal) | 50-60Hz | 50-60Hz | Same |
| Input Voltage | |||
| (nominal) | 100-240VAC | 100-240VAC | Same |
| Input | |||
| Current(rms) | 4A | 4A | Same |
| Name | Subject device | Predicate device | Comparison |
| Device Name | eMVFit(MVF-10M) | EmBody System | |
| Manufacturer | WEERO Co.,Ltd. | INMODE LTD. | |
| 510(k) No. | - | K183450 | |
| RF Frequency | 1 MHz | 1 MHz | Same |
| Vacuum | 50-350 mbar | 200-500 mbar | Different |
| *Note 2 | |||
| RF electrical power | Up to 25 watts | Up to 50 watts | Different |
| *Note 2 | |||
| Cut off Temperature | 32~43°C | 35-43°C | Different |
| *Note 2 | |||
| Standards Met | IEC 60601-1 | ||
| IEC 60601-1-2 | |||
| IEC 60601-2-2 | IEC 60601-1 | ||
| IEC 60601-1-2 | |||
| IEC 60601-2-2 | Same |
6
eMVFit
510(k) Summary
2) Substantial Equivalence Discussion
There are differences on a few things. However, these differences do not affect the significant equivalence of the device and its predicates.
Note 1: "Weight" and "Dimensions"
Although "Weight" and "Dimensions" of subject device are different from the predicate device, they all comply with IEC 60601-1, IEC 60601-2-2, IEC 60601-2-10 requirements, thus the differences of the function specifications does not raise any safety or effectiveness issue.
Note 2:
"Vacuum"
The "Vacuum" of the subject device is within the predicate device's vacuum output range or lower than the predicate device's output. Therefore the difference doesn't impact essential performance, basic safety or substantial equivalence.
"RF electrical power"
Although the "RF electrical power" of the subject device is different than in the predicate device, it was all tested and is compliant with IEC 60601-2-2. Therefore the difference doesn't impact essential performance, basic safety or substantial equivalence.
"Cut off Temperature"
The "Cut off Temperature" of the subject device is within the predicate device's cut off temperature range or lower than the predicate device. Therefore the difference doesn't impact essential performance, basic safety or substantial equivalence.
3) Conclusion
"Embody System" was chosen as predicate for the subject device in consideration of the intended use, indications, performance and principles of operation. Minor variations between the subject and the predicate device were found and listed within the above discussion. Considerable amount of testing, including electrical safety, electromagnetic compatibility, performance, software verification and validation and usability testing were performed to support the claims of appropriately chosen predicate
7
eMVFit
510(k) Summary
device. The test results show that the specifications and performance of eMVFit are as safe and effective as legally marketed predicate devices.
Therefore, it is concluded that the eMVFit is substantially equivalent to the legally marketed predicate devices.
Non-Clinical (Bench) Performance Data: 7.
As part of demonstrating safety and effectiveness of the eMVFit and in showing substantial equivalence to the predicate device that are subject to this 510(k) submission, we completed a number of non-clinical performance tests against applicable standards.
- Basic safety and essential performance of the eMVFit was tested and evaluated according to the IEC 60601-1:2005/A2:2020.
- Effect to the device by electromagnetic disturbances was tested and evaluated according to the FDA-recognized consensus standard IEC 60601-1-2:2014/A1:2020.
- Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories was tested and evaluated according to the IEC 60601-2-2:2017/A1:2023.
- Risk management was recorded by referring to ISO 14971:2019.
- Usability was documented by referring to IEC 60601-1-6:2010/A2:2020.
- Biocompatibility was tested and evaluated according to ISO 10993-5:2009, ISO 10993-10:2021, and ISO 10993-23:2021.
- Software was tested and evaluated according to IEC 62304:2015
- Content of Premarket Submissions for Device Software Functions
The eMVFit passed all the testing in accordance with internal requirements, national standards, and international standards shown above, to support substantial equivalence of the subject device.
Also, to demonstrate that the eMVFit meets all design specifications and performance requirements, and to measure the accuracy of the output parameters of eMVFit and to compare the output parameters with predicate devices, nonclinical bench testing was performed in accordance with the internal process in compliance with the recommendations of the FDA Guidance for Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery.
The testing results support that the requirements for performance and electrical safety were met for the acceptance of the device. The eMVFit passed all testing and supports the claims of substantial equivalence to the predicate device.
Sterilization/Disinfection/Cleaning/Shelf Life 8.
The eMVFit is intended for multiple use and therefore must be cleaned according to the instructions provided in the device Instructions for Use.
There are no sterilized parts or accessories involved with this device.
9. Biocompatibility
| Part | Material | Patient Contact | Duration of
Contact by ISO
10993-1 | Bio-
compatibility |
|--------------------------------------------|---------------|-----------------|------------------------------------------|-----------------------|
| Electrodes of handpiece | SUS 304 | Intact Skin | Limited
(